Covered recipient · General Payments record
NANCY A ARQUETTE
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,684.58
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $265.85 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $58.47 | 3 |
| Exeltis, USA Inc. | $55.91 | 2 |
| Organon LLC | $46.74 | 6 |
| OptumHealth Care Solutions, LLC | $34.42 | 2 |
| Sage Therapeutics, Inc. | $24.30 | 1 |
| PFIZER INC. | $17.14 | 1 |
| Exact Sciences Corporation | $15.54 | 1 |
| Lilly USA, LLC | $13.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $15.45 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139323946 | CMS |
| Astellas Pharma US Inc | $24.84 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139393452 | CMS |
| Astellas Pharma US Inc | $18.18 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139417769 | CMS |
| Exact Sciences Corporation | $15.54 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114579477 | CMS |
| Exeltis, USA Inc. | $23.41 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149985038 | CMS |
| Exeltis, USA Inc. | $32.50 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149985040 | CMS |
| Lilly USA, LLC | $13.33 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135216334 | CMS |
| OptumHealth Care Solutions, LLC | $16.67 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153138810 | CMS |
| OptumHealth Care Solutions, LLC | $17.75 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153138808 | CMS |
| Organon Llc | $1.10 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136237404 | CMS |
| Organon Llc | $13.13 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136237408 | CMS |
| Organon Llc | $14.00 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136237396 | CMS |
| Organon Llc | $2.01 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136237400 | CMS |
| Organon Llc | $1.50 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136237389 | CMS |
| Organon Llc | $15.00 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136237392 | CMS |
| PFIZER INC. | $17.14 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131639715 | CMS |
| Sage Therapeutics, Inc. | $24.30 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120396053 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.